Evidence map›Paper›PMID 22013040›Full record

ArticleJournal of virology2012

Fatal pancreatitis in simian immunodeficiency virus SIV(mac251)-infected macaques treated with 2',3'-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2,3-dioxygenase blockade.

Monica Vaccari, Adriano Boasso, Claudio Fenizia, Dietmar Fuchs, Anna Hryniewicz, Tia Morgan, Deborah Weiss, Melvin N Doster, Jean Michel Heraud, Gene M Shearer and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests.International journal of tryptophan research : IJTR · 2015
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Tim-3, Lag-3, and TIGIT.Current topics in microbiology and immunology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Monica VaccariAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, Maryland, USA.
Adriano Boasso
Claudio Fenizia
Dietmar Fuchs
Anna Hryniewicz
Tia Morgan
Deborah Weiss
Melvin N Doster
Jean Michel Heraud
Gene M Shearer
Genoveffa Franchini
National Institutes of Health · USCenter for Cancer Research · USBioScience Laboratories (United States) · USLudwig Boltzmann Institute for Digital Health and Prevention

Funding

Preventive Vaccines for HIVZIABC011126 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FRANCHINI, GENOVEFFA · 2009 to 2025
$55.3M
Understanding the Role of the Host Response in HIVSIV InfectionZIABC005688 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FRANCHINI, GENOVEFFA · 2009 to 2012
$4.8M
Intramural NIH HHS
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) infection is associated with immune activation, CD4⁺-T-cell loss, and a progressive decline of immune functions. Antiretroviral therapy (ART) only partially reverses HIV-associated immune dysfunction, suggesting that approaches that target immune activation and improve virus-specific immune responses may be needed. We performed a preclinical study in rhesus macaques infected with the pathogenic simian immunodeficiency virus SIV(mac251) and treated with ART. We tested whether vaccination administered together with cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) blockade and treatment with the indoleamine 2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan (D-1mT), decreased immune activation and improved vaccine efficacy. The treatment did not augment vaccine immunogenicity; rather, it dramatically increased ART-related toxicity, causing all treated animals to succumb to acute pancreatitis and hyperglycemic coma. The onset of fulminant diabetes was associated with severe lymphocyte infiltration of the pancreas and complete loss of the islets of Langerhans. Thus, caution should be used when considering approaches aimed at targeting immune activation during ART.

Indexed as

AIDS VaccinesAnimalsAnti-HIV AgentsCTLA-4 AntigenDidanosineDisease Models, AnimalDrug Evaluation, PreclinicalDrug Therapy, CombinationHIV-1HIV InfectionsHumansIndoleamine-Pyrrole 2,3,-DioxygenaseMacaca mulattaPancreatitisSimian Immunodeficiency VirusStavudineAIDS VaccinesAnti-HIV AgentsCTLA-4 AntigenDidanosineIndoleamine-Pyrrole 2,3,-DioxygenaseStavudineTryptophan

Identifiers

PMID22013040
PMCPMC3255892
OpenAlexW2143142600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.